Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile Infection (CDI)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04100603
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionMicrobiome+1 more
ProgenaBiome
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03617172
What this trial is testing

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Who this might be right for
Clostridium Difficile
Vanderbilt University Medical Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Early research (Phase 1)Study completedNCT07251127
What this trial is testing

Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics

Who this might be right for
Clostridium Difficile Infection (CDI)
Gateway Pharmaceutical LLC 18
Testing effectiveness (Phase 2)Looking for participantsNCT06071312
What this trial is testing

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Who this might be right for
Clostridium DifficileUlcerative Colitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 64
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Not applicableStudy completedNCT03710694
What this trial is testing

Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
Da Volterra 260
Testing effectiveness (Phase 2)Ended earlyNCT03795233
What this trial is testing

Fecal Microbiota Transplant for Primary CDI

Who this might be right for
Clostridium Difficile Infection
Boston Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Not applicableUnknownNCT06367504
What this trial is testing

Assess the Effect of Doctor's Biome Medical Food in Individuals With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Vedic Lifesciences Pvt. Ltd. 20
Not applicableStudy completedNCT02214771
What this trial is testing

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Who this might be right for
Clostridium Difficile Infection
Astellas Pharma S.A.S. 296
Post-approval studies (Phase 4)Study completedNCT02437591
What this trial is testing

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridium Difficile Infection (CDI)
Astellas Pharma Europe Ltd. 25
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Not applicableLooking for participantsNCT05257538
What this trial is testing

FMT in Initial CDI

Who this might be right for
Clostridioides Difficile Infection
Turku University Hospital 140
Testing effectiveness (Phase 2)Study completedNCT01259726
What this trial is testing

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Shire 173
Next Page